CVKD
Cadrenal Therapeutics, Inc. Common Stock$2.36-0.06 (-2.48%)Prev Close$2.42·MCap$18.7M·P/E—·Vol46.2K·Yield—
▲
Buys (12M)
0
$0.00
▼
Sells (12M)
23
$1.10M
◆
Net Activity
Net Seller
$1.10M
●
Active Insiders
2
last 12 mo
Over the past 12 months, insider activity at Cadrenal Therapeutics, Inc. Common Stock (CVKD) has been exclusively selling, with 0 insider purchases totaling $0.00 and 23 insider sales totaling $1.10M. The most recent insider transaction was by Pham Quang X (director, 10 percent owner, officer: Chairman and CEO), who sold $22.4K worth of shares on Jul 1, 2026. Cadrenal Therapeutics, Inc. Common Stock operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $18.7M.
CVKD Insider Trading Activity
CVKD Insider Buying Activity
The following table shows recent insider purchases of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.
CVKD Insider Selling Activity
The following table shows recent insider sales of Cadrenal Therapeutics, Inc. Common Stock (CVKD) stock reported via SEC Form 4 filings.